VKTX - Company ID 0001607678
As of 2026-11-06, Viking Therapeutics, Inc. (VKTX) has a market capitalization of $2.99 B, making it the #1801 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $2.99 B |
| 2026-11-05 | $2.99 B |
| 2026-11-04 | $3.25 B |
| 2026-11-03 | $3.10 B |
| 2026-11-02 | $3.10 B |
| 2026-11-01 | $3.17 B |
| 2026-10-31 | $3.17 B |
| 2026-10-30 | $3.17 B |
| 2026-10-29 | $3.12 B |
| 2026-10-28 | $2.94 B |
| 2026-10-27 | $2.89 B |
| 2026-10-26 | $2.80 B |
As of 2026-11-06, Viking Therapeutics, Inc. (VKTX) has a market capitalization of $2.99 B, making it the #1801 most valuable US-listed company.
Viking Therapeutics, Inc. is the #1801 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $2.83 B |
| 2026-10-24 | $2.83 B |
| 2026-10-23 | $3.00 B |
| 2026-10-22 | $3.00 B |
| 2026-10-21 | $3.06 B |
| 2026-10-20 | $3.10 B |
| 2026-10-19 | $2.91 B |
| 2026-10-18 | $2.92 B |
| 2026-10-17 | $2.92 B |
| 2026-10-16 | $2.92 B |
| 2026-10-15 | $3.18 B |
| 2026-10-14 | $2.96 B |
| 2026-10-13 | $3.09 B |
| 2026-10-12 | $3.29 B |
| 2026-10-11 | $3.31 B |
| 2026-10-10 | $3.31 B |
| 2026-10-09 | $3.32 B |
| 2026-10-08 | $3.22 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.